O'nyong-nyong fever: a neglected mosquito-borne viral disease.
Rezza G, Chen R, Weaver SC.
Pathog Glob Health. 2017 Sep;111(6):271-275. doi: 10.1080/20477724.2017.1355431. Epub 2017 Aug 22.
Chikungunya virus infection: an overview.
Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L.
New Microbiol. 2013 Jul;36(3):211-27. Epub 2013 Jun 30.
FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design.
Ng WH, Liu X, Ling ZL, Santos CNO, Magalhães LS, Kueh AJ, Herold MJ, Taylor A, Freitas JR, Koit S, Wang S, Lloyd AR, Teixeira MM, Merits A, Almeida RP, King NJC, Mahalingam S.
Nat Commun. 2023 Oct 26;14(1):6605. doi: 10.1038/s41467-023-42330-2.
Determinants of Chikungunya and O'nyong-Nyong Virus Specificity for Infection of Aedes and Anopheles Mosquito Vectors.
Cottis S, Blisnick AA, Failloux AB, Vernick KD.
Viruses. 2023 Feb 21;15(3):589. doi: 10.3390/v15030589.
GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics.
Pezzi L, Reusken CB, Weaver SC, Drexler JF, Busch M, LaBeaud AD, Diamond MS, Vasilakis N, Drebot MA, Siqueira AM, Ribeiro GS, Kohl A, Lecuit M, Ng LFP, Gallian P, de Lamballerie X; GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group.
Antiviral Res. 2019 Jun;166:66-81. doi: 10.1016/j.antiviral.2019.03.009. Epub 2019 Mar 21.
GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 5: Entomological aspects.
Pezzi L, Diallo M, Rosa-Freitas MG, Vega-Rua A, Ng LFP, Boyer S, Drexler JF, Vasilakis N, Lourenco-de-Oliveira R, Weaver SC, Kohl A, de Lamballerie X, Failloux AB; GloPID-R chikungunya, o'nyong-nyong and Mayaro virus Working Group.
Antiviral Res. 2020 Feb;174:104670. doi: 10.1016/j.antiviral.2019.104670. Epub 2019 Dec 5.
O'nyong-nyong (ONN) fever.
[No authors listed]
Wkly Epidemiol Rec. 1997 Mar 28;72(13):93.
[O'NYONG-NYONG FEVER].
NUTI M.
Arch Ital Sci Med Trop Parassitol. 1965 May-Jun;46:293-6.
O'nyong-nyong fever in south-central Uganda, 1996-1997: clinical features and validation of a clinical case definition for surveillance purposes.
Kiwanuka N, Sanders EJ, Rwaguma EB, Kawamata J, Ssengooba FP, Najjemba R, Were WA, Lamunu M, Bagambisa G, Burkot TR, Dunster L, Lutwama JJ, Martin DA, Cropp CB, Karabatsos N, Lanciotti RS, Tsai TF, Campbell GL.
Clin Infect Dis. 1999 Nov;29(5):1243-50. doi: 10.1086/313462.
GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 3: Epidemiological distribution of Mayaro virus.
Pezzi L, Rodriguez-Morales AJ, Reusken CB, Ribeiro GS, LaBeaud AD, Lourenço-de-Oliveira R, Brasil P, Lecuit M, Failloux AB, Gallian P, Jaenisch T, Simon F, Siqueira AM, Rosa-Freitas MG, Vega Rua A, Weaver SC, Drexler JF, Vasilakis N, de Lamballerie X; GloPID-R chikungunya, o'nyong-nyong and Mayaro virus Working Group.
Antiviral Res. 2019 Dec;172:104610. doi: 10.1016/j.antiviral.2019.104610. Epub 2019 Sep 20.
